Connor, Clark & Lunn Investment Management Ltd. - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 92 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$711,522
+26.5%
624,142
+1.5%
0.00%
+33.3%
Q2 2023$562,613
+231.4%
614,878
+102.9%
0.00%
+200.0%
Q1 2023$169,788
+145.1%
302,977
+152.4%
0.00%
Q4 2022$69,271
-57.0%
120,053
-76.5%
0.00%
-100.0%
Q3 2022$161,000
+101.2%
510,102
+124.9%
0.00%
Q2 2022$80,000
-76.4%
226,770
-51.9%
0.00%
-100.0%
Q1 2022$339,000
-62.7%
471,681
+17.2%
0.00%
-50.0%
Q4 2021$909,000
-26.7%
402,416
-6.6%
0.00%
-33.3%
Q3 2021$1,240,000
+54.8%
430,671
+103.8%
0.01%
+50.0%
Q2 2021$801,000
+160.9%
211,290
+133.1%
0.00%
+100.0%
Q1 2021$307,000
+13.3%
90,657
+559.1%
0.00%0.0%
Q3 2017$271,000
-56.9%
13,755
-68.6%
0.00%
-50.0%
Q2 2017$629,000
+424.2%
43,800
+172.0%
0.00%
+300.0%
Q2 2016$120,000
-80.5%
16,100
-76.4%
0.00%
-80.0%
Q1 2016$614,000
-51.5%
68,200
-30.4%
0.01%
-54.5%
Q4 2015$1,265,000
+46.4%
97,925
+9.5%
0.01%
+57.1%
Q3 2015$864,000
+127.4%
89,425
+142.3%
0.01%
+133.3%
Q2 2015$380,000
+42.9%
36,900
+54.4%
0.00%
+50.0%
Q1 2015$266,000
+67.3%
23,900
+74.5%
0.00%
+100.0%
Q4 2014$159,00013,7000.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders